Open AccessRecombinant Activated Factor VII in Aortic Surgery for Patients Under Hypothermic Circulatory Arrest
Author(s) -
Hayato Ise,
Ryohei Ushioda,
Hirotsugu Kanda,
Fumiaki Kimura,
Yasuaki Saijo,
Payam Akhyari,
Artur Lichtenberg,
Hiroyuki Kamiya
Publication year - 2022
Publication title -
therapeutics and clinical risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.719
H-Index - 55
eISSN - 1178-203X
pISSN - 1176-6336
DOI - 10.2147/tcrm.s352609
Subject(s) - medicine , partial thromboplastin time , deep hypothermic circulatory arrest , perioperative , propensity score matching , anesthesia , cohort , prothrombin time , fibrinogen , surgery , cardiac surgery , platelet , cerebral perfusion pressure , cerebral blood flow
We aimed to identify the risk factors of critical bleeding and investigate the safety of recombinant activated factor VII (rFVIIa) in aortic surgery under hypothermic circulatory arrest (HCA).